首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >First glimpse of the peptide presentation by rhesus macaque MHC class I: crystal structures of Mamu-A*01 complexed with two immunogenic SIV epitopes and insights into CTL escape.
【24h】

First glimpse of the peptide presentation by rhesus macaque MHC class I: crystal structures of Mamu-A*01 complexed with two immunogenic SIV epitopes and insights into CTL escape.

机译:猕猴类MHC I类首次呈现肽段:Mamu-A * 01的晶体结构与两个免疫原性SIV表位复合,并深入了解CTL逃逸。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The infection of rhesus macaques (Macaca mulatta) by the SIV is the best animal model for studying HIV infection and for AIDS vaccine development. A prevalent MHC class I allele, Mamu-A*01, is known to correlate with containment of SIV, which has been extensively explored in studies of CTL-based vaccination concepts. We determined the crystal structures of Mamu-A*01 complexed with two immunodominant SIV epitopes: the nonamer CM9 of group-specific Ag (Gag, 181-189; CTPYDINQM) and the octamer TL8 of transcription activator (Tat, 28-35; TTPESANL). The overall structures of the two Mamu-A*01 complexes are similar to other MHC class I molecules. Both structures confirm the presence of an absolutely conserved proline anchor residue in the P3 position of the Ag, bound to a D pocket of the Mamu-A*01 H chain with optimal surface complementarity. Like other MHC/peptide complex structures, the P2 and C-terminal residues of the epitopes are also important for anchoring to the MHC molecule, whereas the middle residues form an arch and their side chains are directed into solvent. These two structures reveal details of how Mamu-A*01 interacts with two well-studied epitopes at the atomic level. We discuss the structural basis of CTL escape, based on molecular models made possible by these two structures. The results we present in this study are most relevant for the rational design of Mamu-A*01-restricted CTL epitopes with improved binding, as a step toward development of AIDS vaccines.
机译:SIV感染恒河猴(猕猴)是研究HIV感染和开发AIDS疫苗的最佳动物模型。众所周知,MHC I类流行等位基因Mamu-A * 01与SIV的感染相关,在基于CTL的疫苗接种概念的研究中已广泛探索了SIV。我们确定了与两个免疫优势SIV表位复合的Mamu-A * 01的晶体结构:群特异性Ag的九聚体CM9(Gag,181-189; CTPYDINQM)和转录激活因子的八聚体TL8(Tat,28-35; TTPESANL )。两个Mamu-A * 01配合物的整体结构与其他MHC I类分子相似。两种结构均证实在Ag的P3位置存在绝对保守的脯氨酸锚残基,该残基以最佳的表面互补性结合到Mamu-A * 01 H链的D口袋。像其他MHC /肽复合物结构一样,表位的P2和C末端残基对于锚定到MHC分子上也很重要,而中间残基形成一个弓形,其侧链直接进入溶剂。这两个结构揭示了Mamu-A * 01如何与两个经过充分研究的表位在原子水平上相互作用的细节。我们基于这两种结构可能形成的分子模型,讨论了CTL逃逸的结构基础。我们在这项研究中提出的结果与结合改善的Mamu-A * 01限制性CTL表位的合理设计最相关,是开发AIDS疫苗的一步。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号